MarketPulse

minimal residual disease

3 articles
BenzingaBenzinga··Vandana Singh

Natera Positioned to Capture $20B MRD Market as Testing Adoption Accelerates

William Blair initiates Natera coverage, citing $1B MRD revenue in 2025 with 40%+ growth expected in 2026 as penetration rises.
NTRAmarket opportunitycompetitive advantage
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Oncology Biomarkers Market to Double by 2030 as AI, Liquid Biopsies Drive Growth

Global oncology biomarkers market projected to grow from $17.3B (2025) to $33.63B (2030) at 14.3% CAGR, driven by AI, liquid biopsies, and precision medicine adoption.
NVSILMNRHHBYTMOGHpersonalized medicinecancer diagnostics
BenzingaBenzinga··Vandana Singh

Nvidia GPU Tech Cuts Cancer Detection Time to Hours, Partners With Droplet Biosciences

Nvidia and Droplet Biosciences partnership cuts cancer detection to 24 hours post-surgery using GPU-accelerated genomics, reducing computational time 92% and costs 30%.
NVDAcancer detectionGPU acceleration